| Similar Articles |
|---|
 |
Information Today
March 26, 2007 |
Thomson Scientific Acquires Unleashed Informatics Thomson announced that it has acquired Unleashed Informatics, a life sciences data-management company that owns the largest repository of value-added bioinformatics records -- a significant area for target-based drug discovery.   |
Information Today
January 4, 2010 |
Thomson Reuters Links Drug Discovery and Literature Citation Databases Thomson Reuters announced it has connected its drug discovery database, Prous Science Integrity, to Web of Knowledge, its research platform. |
Information Today
August 4, 2011 |
Elsevier Introduces Genome Viewer The Genome Viewer is a SciVerse application that displays detailed gene or genomic sequence information on the genes mentioned in an article. |
Bio-IT World
Jul/Aug 2006
Deb Janssen |
Managing the Microarray Data Mountain Genomic studies often involve thousands of samples and require hundreds of thousands of assays per sample. Microarray manufacturers are scurrying to satisfy researcher demands for increased array density, sample number, and content flexibility. |
Bio-IT World
August 15, 2005
Robert M. Frederickson |
What's 'Post' About Postgenomic? Bioinformatics tools can help organize and study genomic sequences that were discovered in the '90s. The tools help with tasks like analyzing gene expression, predicting protein structure and function, and establishing networks of interacting protein in cells. |
Reactive Reports
Apr/May 2005
David Bradley |
At Last, the Structure of DNA Researchers have made a significant advance in our understanding of life's main molecule, using X-ray crystallography to determine the three-dimensional structures of nearly all the possible sequences of a macromolecule. |
Bio-IT World
July 11, 2002
Malorye Branca |
Deep Sequence Diving Like sailors of old, genomic data miners dream of discovering riches and fame. Given the recent improvements in analytics -- and a little more time -- they just might succeed. |
Industrial Physicist
Jennifer Ouellette |
Bioinformatics moves into the mainstream An explosion of data is being tamed with new systems |
Information Today
October 27, 2003
Barbara Quint |
BIOSIS Sold to Thomson Scientific Five months after announcing its search for a partner, Biological Abstracts' board of trustees announced that it had entered final negotiations with Thomson Corp. |
Bio-IT World
July 15, 2003 |
Millennium's PARIS Illuminates Pathways To address high-throughput-data challenges, Millennium Pharmaceuticals built the PAthway Resource and Information System, or PARIS -- a unique platform for combining knowledge from heterogeneous data sources in the construction of a pathway knowledgebase. |
Information Today
February 25, 2008 |
Thomson Scientific to Use Collexis' Knowledge Dashboard in Custom Solution Plans to join Collexis' Knowledge Dashboard with Thomson Scientific's Web of Science will create a custom data mining solution for the research community. |
Bio-IT World
April 15, 2003
Malorye Branca |
Beyond the Blueprint How will the wealth of data emanating from the human genome and allied technologies impact research on health and disease? |
Bio-IT World
June 2006
Kevin Davies |
The Data Deluge: Deal or No Deal? Far from decrying the data glut, researchers should embrace the complexity of genomic and other sources of data, particularly for its predictive properties in the field of personalized medicine. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Information Today
December 17, 2012 |
Thomson Reuters Relaunches Bibliometric Resource--ScienceWatch.com The IP & Science business of Thomson Reuters announced the relaunch of ScienceWatch.com, an open, web-based resource dedicated to scientific metrics and research performance analysis. |
Information Today
February 13, 2012 |
Elsevier Launches TargetInsights for Early Drug Discovery This online decision support tool enables scientists to search, monitor, and stay up-to-date with the latest biological insights reported in the scientific literature. |
Bio-IT World
November 2006
Kevin Davies |
The Quest to Make Sequence Sense With the human genome sequenced several years ago, the challenge for biopharma organizations mining this invaluable trove of data is evolving. |
Bio-IT World
November 12, 2002
James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success. |
HHMI Bulletin
May 2012 |
Institute Launches New Investigator Competition These appointments will enable the Howard Hughes Medical Institute to strengthen its community of researchers and bring innovative approaches to the study of biological problems. |
Bio-IT World
May 7, 2002
Anthony Strattner |
Molecular Machining Blending nanotechnology with bioengineering, researchers at engeneOS use genomic information as engineerable parts to build biomolecules. |
Information Today
January 7, 2010 |
Thomson Reuters Acquires Discovery Logic, Inc. The acquisition is designed to enhance current research analytics offerings and provide increased decision support and workflow solutions to academic, government, nonprofit, and commercial professionals. |
IEEE Spectrum
March 2011
Lucks & Arkin |
Synthetic Biology's Hunt for the Genetic Transistor How genetic circuits will unlock the true potential of bioengineering |
Information Today
September 17, 2012 |
Thomson Reuters Launches Sustainability Website The website will enable dialogue and support customers and engaged citizens in their efforts to find a more sustainable pathway for their businesses and communities. |
Bio-IT World
December 15, 2004
Salvatore Salamone |
IBM, SGI Earn Top Bragging Rights at SC2004 Conference BlueGene/L and Altix 1.5GHz, Infiniband place first and second respectively on the Top 500 list of the world's most powerful supercomputers. However, bioscience problems remain. |
Bio-IT World
October 10, 2003
Donna Mendrick |
Microarrays That Make Drugs Safe Using DNA chips to discover potential toxicity in new drug compounds -- a key application of toxicogenomics -- can predict adverse effects before they occur, enabling safer clinical trials. |
Bio-IT World
November 12, 2002
Beth E. Arnold |
Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield. |
Bio-IT World
July 14, 2004
Malorye A. Branca |
The Pathways Promise By using the right tools, even a modest genomic data set can generate a good view into a particular biological pathway. Now, a range of new technologies is arising from academia as well as the commercial sector to meet this need. |
Information Today
April 29, 2010 |
Thomson Reuters and WIPO Launch Free Patent Information Access in Developing Countries The aim of the program, which is due to launch in September 2010, is to foster global innovation by enabling the development of solutions to the world's technical challenges. |
BusinessWeek
May 9, 2005
John Carey |
Dr. Francis S. Collins: On The Trail Of Disease Genes Collins is leading the search for DNA variations that can result in illnesses. |
Wired
April 21, 2008
Rachel Swaby |
Chromosome, Proteome ... Decoding the DNA of '-omes' The genome alone can't explain how our bodies work. We need to decode a lot of other complex biological systems that regulate how we develop. |
Chemistry World
February 2012 |
Column: The crucible To understand the chemical choreography of the cell, we must acknowledge the bustling biomolecular ballroom in which it takes place, says Philip Ball |
Bio-IT World
October 14, 2004
William Pulleyblank |
Rewriting the Rulebook for Supercomputing and Research IBM's Blue Gene supercomputer project leader highlights progress and future applications. |
Bio-IT World
March 8, 2005
Kevin Davies |
Evolution of New Genes Studied EMBL researchers use comparative genomic analysis to identify new primate-specific gene family. |
Information Today
December 10, 2007
Paula J. Hane |
Thomson Scientific Launches Innovation for IP Research and Analysis Thomson Innovation is a new intellectual property research and analysis solution that integrates patent data with scientific literature and business information in a single platform that also provides analytical and workflow tools. |
Information Today
September 2, 2003
Barbara Quint |
Thomson Acquires Techstreet Thomson Scientific and Healthcare has acquired a new operation in a move aimed at adding the standards and specifications literature to its document delivery services. |
Salon.com
May 1, 2000
Arthur Allen |
Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic. |
Information Today
November 29, 2004
Paula J. Hane |
Thomson Announces New Pharma Research Tool The Thomson Corp. is using the Online Information exhibition in London for the official launch of its new integrated research tool for the pharmaceutical and biotech industries. |
Wired
January 2005
Oliver Morton |
Life, Reinvented A group of MIT engineers wanted to model the biological world. But, damn, some of nature's designs were complicated! So they started rebuilding from the ground up - and gave birth to synthetic biology. |
Technology Research News
March 26, 2003 |
Plastic coating makes chips biofriendly Electronics usually don't mix well with biological material. Sandia National Laboratories researchers have overcome the incompatibility with a microscopic laser designed to quickly measure and identify microorganisms and cell types without inhibiting biological processes. |
Information Today
November 14, 2011
Tara Breton |
New Pharmaceutical Information Tool Coming From Thomson Reuters--Cortellis The content of the system at the moment is limited to competitive intelligence, pipeline information gleaned from sources such as Thomson Reuters Pharma, and patent information from Dolphin. |
